• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    5/23/23 1:46:33 PM ET
    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Get the next $ABCL alert in real time by email

    Gainers

    • CohBar, Inc. (NASDAQ:CWBR) shares jumped 161% to $4.05 after the company and Morphogenesis announced they have entered into a definitive agreement for an all-stock transaction forming a company combining expertise and resources to advance a late-stage oncology pipeline.
    • HeartCore Enterprises, Inc. (NASDAQ:HTCR) gained 76.6% to $2.26 following better-than-expected first-quarter results.
    • Ocean Biomedical, Inc. (NASDAQ:OCEA) shares climbed 63% to $8.57 after the company announced a patent award for novel cancer immunotherapy treatment, granted for prostate cancer, colon cancer, ovarian cancer, kidney cancer, breast cancer, glioblastoma, melanoma and lung cancer.
    • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) surged 44% to $1.50 after it was granted U.S. patent #11654157: Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation.
    • Unique Fabricating, Inc. (NYSE:UFAB) climbed 32.8% to $0.2599 after the company announced an accommodation agreement and new forbearance agreement to support a restructuring or sale.
    • Icosavax, Inc. (NASDAQ:ICVX) gained 29.7% to $10.21 after the company announced topline interim Phase 1 results for its bivalent VLP vaccine candidate IVX-A12 against RSV and hMPV in older adults.
    • mCloud Technologies Corp. (NASDAQ:MCLD) jumped 27% to $0.4567 after the company announced it has formed a special committee for the purpose of exploring strategic alternatives.
    • Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) gained 22.6% to $9.96.
    • IMAC Holdings, Inc. (NASDAQ:BACK) climbed 21.9% to $0.1702. Theralink signed definitive merger agreement to be acquired by IMAC Holdings.
    • TuSimple Holdings Inc. (NASDAQ:TSP) climbed 21.2% to $2.01.
    • Lexaria Bioscience Corp. (NASDAQ:LEXX) climbed 20.4% to $0.83. Lexaria Bioscience recently announced it completed its HOR-A22-1 study that showed significant enhancement in the oral delivery of the estrogen hormone estradiol.
    • PacWest Bancorp (NASDAQ:PACW) shares gained 20% to $8.23. PacWest Bancorp shares jumped around 20% on Monday after the company announced it entered into a loan purchase and sale agreement with a subsidiary of Kennedy-Wilson Holdings to sell a portfolio of 74 real estate construction loans. DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8.
    • Lifecore Biomedical, Inc. (NASDAQ:LFCR) shares gained 18% to $6.32 after the company announced it entered into $150 million in new financing, repaid its outstanding term loans and signed a new supply agreement to expact its HA fermentation capacity with Alcon.
    • Quanterix Corporation (NASDAQ:QTRX) gained 17.5% to $22.59. Goldman Sachs upgraded Quanterix from Neutral to Buy and raised the price target from $13 to $27.
    • Applied UV, Inc. (NASDAQ:AUVI) shares climbed 15.6% to $0.5512 after posting better-than-expected quarterly sales.
    • Angion Biomedica Corp. (NASDAQ:ANGN) gained 15.1% to $0.9159.
    • SeqLL Inc. (NASDAQ:SQL) shares surged 15% to $0.46 after gaining over 19% on Monday. SeqLL recently posted a wider first-quarter loss.
    • Navigator Holdings Ltd. (NYSE:NVGS) rose 14.2% to $15.00 following strong quarterly sales.
    • Myriad Genetics, Inc. (NASDAQ:MYGN) gained 12.9% to $22.67. Goldman Sachs upgraded Myriad Genetics from Sell to Buy and raised the price target from $18 to $25.
    • Sarcos Technology and Robotics Corporation (NASDAQ:STRC) surged 11.7% to $0.3857.
    • Wallbox N.V. (NYSE:WBX) surged 11.2% to $3.9583.
    • Terns Pharmaceuticals, Inc. (NASDAQ:TERN) jumped 11.2% to $12.55.
    • AbCellera Biologics Inc. (NASDAQ:ABCL) gained 11% to $7.34.
    • Movella Holdings Inc. (NASDAQ:MVLA) rose 9.9% to $2.11 after jumping around 18% on Monday.
    • CureVac N.V. (NASDAQ:CVAC) surged 9.5% to $10.59.
    • Yelp Inc. (NYSE:YELP) gained 9.2% to $35.51. Activist investor TCS Capital Management has built a stake in Yelp and urged the service-recommendation site to explore strategic alternatives, including a sale, the Wall Street Journal reported.
    • Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) shares rose 5.8% to $1.84. The FDA recently approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in infants.

    Losers

    • Netcapital Inc. (NASDAQ:NCPL) shares fell 32.8% to $1.62 after the company reported a registered direct offering of 1.1 million shares at $1.55 per share.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) dropped 29% to $0.2001 after the company posted downbeat quarterly results and announced exploration of strategic alternatives and implementation of a restructuring program, including 30% incremental reduction of workforce completed this past week.
    • Kaspien Holdings Inc. (NASDAQ:KSPN) fell 27.6% to $0.4427. Kaspien Holdings reported voluntary delisting from the Nasdaq Capital Market effective on or about June 12.
    • Evolve Transition Infrastructure LP (NYSE:SNMP) dipped 26.6% to $0.0901 after the company announced a 1-for-30 reverse split.
    • Microvast Holdings, Inc. (NASDAQ:MVST) fell 22.3% to $1.71 after the US Energy Department reportedly cancelled contract negotiations for a $200 million award for the company.
    • Microbot Medical Inc. (NASDAQ:MBOT) fell 22.1% to $2.4850. Microbot Medical announced a $1.44 million registered direct offering of 655,569 shares of common stock at a price of $2.20 per share priced at the market under Nasdaq rules.
    • NantHealth, Inc. (NASDAQ:NH) fell 20.6% to $2.04.
    • Oncorus, Inc. (NASDAQ:ONCR) dropped 20% to $0.2480 after the company reported Q1 financial results.
    • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) dropped 20% to $2.96.
    • D-Wave Quantum Inc. (NYSE:QBTS) fell 16.7% to $0.8501 after surging 110% on Monday.
    • Tenon Medical, Inc. (NASDAQ:TNON) declined 16.1% to $1.36. Tenon Medical recently posted downbeat quarterly results.
    • NexImmune, Inc. (NASDAQ:NEXI) dropped 15.2% to $0.4018.
    • Achieve Life Sciences, Inc. (NASDAQ:ACHV) declined 14.7% to $6.95 as the company reported topline results from Phase 3 ORCA-3 trial of cytisinicline.
    • Integra LifeSciences Holdings Corporation (NASDAQ:IART) fell 13.5% to $43.87 after the company announced it initiated a voluntary global recall of all products manufactured in its Boston facility distributed between March 1, 2018 and May 22, 2023.
    • Voyager Therapeutics, Inc. (NASDAQ:VYGR) fell 10.6% to $12.37.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) dropped 10% to $4.2750 following weak quarterly results.
    • Biocept, Inc (NASDAQ:BIOC) shares dropped 9.6% to $4.4491 dipping over 25% on Monday. Biocept recently announced a 1-for-30 reverse stock split.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 9.1% to $0.9277 after reporting results for its first quarter.
    • Peraso Inc. (NASDAQ:PRSO) fell 8.3% to $0.3650 after gaining over 53% on Monday.
    • Zoom Video Communications, Inc. (NASDAQ:ZM) dropped 7% to $66.42. Zoom Video reported better-than-expected results for its first quarter and raised its full-year sales outlook.
    • BJ's Wholesale Club Holdings, Inc. (NYSE:BJ) dropped 6.4% to $65.18 following weak quarterly sales.

     

    Now Read This: Dow Drops Over 100 Points; Lowe's Earnings Top Views

    Get the next $ABCL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABCL
    $ACHV
    $ANGN
    $AUVI

    CompanyDatePrice TargetRatingAnalyst
    Terns Pharmaceuticals Inc.
    $TERN
    3/25/2026Buy → Neutral
    H.C. Wainwright
    Lifecore Biomedical Inc.
    $LFCR
    3/17/2026$5.50Mkt Perform → Outperform
    Barrington Research
    D-Wave Quantum Inc.
    $QBTS
    2/12/2026Buy
    TD Cowen
    Kingsoft Cloud Holdings Limited
    $KC
    2/11/2026$15.60Neutral → Buy
    Goldman
    Microbot Medical Inc.
    $MBOT
    2/10/2026$5.00Buy
    B. Riley Securities
    Terns Pharmaceuticals Inc.
    $TERN
    2/9/2026$58.00Outperform
    Leerink Partners
    Zoom Communications Inc.
    $ZM
    2/5/2026$115.00Peer Perform → Outperform
    Wolfe Research
    BJ's Wholesale Club Holdings Inc.
    $BJ
    1/28/2026$90.00Buy → Hold
    Jefferies
    More analyst ratings

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Raha Samraat S. bought $199,844 worth of shares (40,000 units at $5.00), increasing direct ownership by 9% to 493,104 units (SEC Form 4)

    4 - MYRIAD GENETICS INC (0000899923) (Issuer)

    3/9/26 7:03:13 PM ET
    $MYGN
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Large owner Thermopylae Holdings Ltd. bought $130,720 worth of shares (38,000 units at $3.44), increasing direct ownership by 0.07% to 56,134,097 units (SEC Form 4)

    4 - AbCellera Biologics Inc. (0001703057) (Issuer)

    3/2/26 2:16:40 PM ET
    $ABCL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Phanstiel S. Louise bought $494,722 worth of shares (104,507 units at $4.73), increasing direct ownership by 59% to 281,951 units (SEC Form 4)

    4 - MYRIAD GENETICS INC (0000899923) (Issuer)

    2/27/26 4:46:18 PM ET
    $MYGN
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    CHASKA, Minn., March 26, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore") a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced that effective on March 25, 2026, Lifecore granted a restricted stock unit ("RSU") award with respect to 18,500 shares of its common stock under Lifecore's Equity Inducement Plan, as amended (the "Inducement Plan") to a newly hired employee of Lifecore. The RSU award was granted pursuant to the offer letter between Lifecore and the employee, and as a material inducement to the employee joining Lifecore. The RSU award was approved by Lifecore's compensation committee and was grante

    3/26/26 4:05:00 PM ET
    $LFCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability

    SEATTLE and VANCOUVER, British Columbia, March 26, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced the publication of a manuscript in Nicotine & Tobacco Research describing the receptor selectivity profile of cytisinicline. This study provides mechanistic characterization of cytisinicline's receptor selectivity profile, which informs understanding of its favorable tolerability. There have been no new FDA-approved treatments for smoking cessation in 20 years, and there are currently no FDA-approved

    3/26/26 8:30:00 AM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®'s LIBERTY® Endovascular Robotic System

    World's first robotic Prostatic Artery Embolization (PAE) for Benign Prostatic Hyperplasia (BPH) and robotic Y-90 radioembolization mapping for liver cancer are among the robotic cases performed using the LIBERTY System, demonstrating system adoption across multiple case types ATLANTA and HINGHAM, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- Emory Healthcare has successfully completed robotic peripheral endovascular procedures — minimally invasive treatments for certain vascular conditions — using Microbot Medical's (NASDAQ:MBOT) LIBERTY® Endovascular Robotic System. Microbot believes that the application of the single-use robotic system can expand patient access to high-quality care. Emory

    3/26/26 8:30:00 AM ET
    $MBOT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Qu Heng

    3 - Kingsoft Cloud Holdings Ltd (0001795589) (Issuer)

    3/26/26 9:07:45 AM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Montgomery Jeanine

    4 - Strategy Inc (0001050446) (Issuer)

    3/25/26 8:28:56 PM ET
    $STRC
    Wholesale Distributors
    Industrials

    SEC Form 4 filed by Kang Andrew

    4 - Strategy Inc (0001050446) (Issuer)

    3/25/26 8:28:35 PM ET
    $STRC
    Wholesale Distributors
    Industrials

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by D-Wave Quantum Inc.

    SCHEDULE 13G/A - D-Wave Quantum Inc. (0001907982) (Subject)

    3/26/26 5:39:25 PM ET
    $QBTS
    EDP Services
    Technology

    SEC Form 10-K filed by Microbot Medical Inc.

    10-K - Microbot Medical Inc. (0000883975) (Filer)

    3/26/26 4:30:47 PM ET
    $MBOT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by BJ's Wholesale Club Holdings Inc.

    SCHEDULE 13G/A - BJ's Wholesale Club Holdings, Inc. (0001531152) (Subject)

    3/26/26 4:10:02 PM ET
    $BJ
    Department/Specialty Retail Stores
    Consumer Discretionary

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Terns Pharmaceuticals downgraded by H.C. Wainwright

    H.C. Wainwright downgraded Terns Pharmaceuticals from Buy to Neutral

    3/25/26 10:23:07 AM ET
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lifecore Biomedical upgraded by Barrington Research with a new price target

    Barrington Research upgraded Lifecore Biomedical from Mkt Perform to Outperform and set a new price target of $5.50

    3/17/26 7:45:07 AM ET
    $LFCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TD Cowen initiated coverage on D-Wave Quantum

    TD Cowen initiated coverage of D-Wave Quantum with a rating of Buy

    2/12/26 7:24:12 AM ET
    $QBTS
    EDP Services
    Technology

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Financials

    Live finance-specific insights

    View All

    Kingsoft Cloud Announces Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results

    BEIJING, March 25, 2026 /PRNewswire/ -- Kingsoft Cloud Holdings Limited ("Kingsoft Cloud" or the "Company") (NASDAQ:KC), a leading cloud service provider in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Mr. Tao Zou, Chief Executive Officer of Kingsoft Cloud, commented, "We are very pleased to see another strong quarter to close the fiscal year of 2025. Our record-high financial result is a powerful testament to the confidence our customers place in our products, solutions and services. This quarter our gross billing of AI business achieved a year-over-year growth of 95%, and we continue to see strong intelligent computi

    3/25/26 7:57:00 AM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

    Achieve also Announces Partnership with U.S.-based Adare Pharma Solutions for Cytisinicline Manufacturing Conference Call Scheduled for 8:30 AM EDT Today, March 24, 2026 SEATTLE and VANCOUVER, British Columbia, March 24, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve) (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced financial results for the fourth quarter and full year 2025 and provided updates on the cytisinicline development program, including the announcement of its partnership with Adare Pharma Solutions (Adare). "Achieve is full

    3/24/26 7:00:00 AM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Netcapital Reports Third Quarter Fiscal 2026 Financial Results and Provides Corporate Update

    Key milestones include acquisition of Iverson Design and signing PureWave Hydrogen as first tokenization clientManagement to host business update conference call tomorrow at 10:00 am ET BOSTON, MA, March 19, 2026 (GLOBE NEWSWIRE) -- Netcapital Inc. (NASDAQ:NCPL, NCPLW, Netcapital)) (the "Company"), a digital private capital markets ecosystem, today announced financial results and provided corporate highlights for the third quarter of fiscal 2026 ended January 31, 2026. In addition, management plans to host a business update conference call tomorrow, March 20, 2026, at 10:00 a.m. ET. "We completed several key transactions in fiscal Q3 2026," said Rich Wheeless, Netcapital's Chief Executiv

    3/19/26 5:57:00 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Leadership Updates

    Live Leadership Updates

    View All

    Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer

    Salt Lake City, UT, March 25, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Vicki Goodman, M.D., will become Recursion's Chief Medical Officer effective April 6, 2026 as David Mauro, M.D., Ph.D. transitions out of the role. As Recursion advances its pipeline and prepares for key clinical and regulatory milestones, which are consistent with previously communicated expectations, Dr. Goodman brings a rare and differentiated perspective of how to translate scientific promise into successful clinical programs. Her experience spans executive roles in biotech and large pharma, with p

    3/25/26 7:59:00 AM ET
    $RXRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

    MALVERN, Pa., March 17, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM) (the "Company"), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, today announced the appointment of Dan Reuvers as the Company's next President and Chief Executive Officer, effective March 23, 2026. Mr. Reuvers will also join the Board of Directors at that time. He succeeds Keith Sullivan, who will step down as the Company's President and Chief Executive Officer on March 23, 2026 and retire on March 31, 2026 after five and a half years of leadin

    3/17/26 7:45:00 AM ET
    $IART
    $STIM
    $TCMD
    Medical/Dental Instruments
    Health Care

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Microvast Holdings Inc.

    SC 13D/A - Microvast Holdings, Inc. (0001760689) (Subject)

    11/21/24 9:41:30 PM ET
    $MVST
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by Terns Pharmaceuticals Inc.

    SC 13G/A - Terns Pharmaceuticals, Inc. (0001831363) (Subject)

    11/15/24 10:35:07 AM ET
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by D-Wave Quantum Inc.

    SC 13G/A - D-Wave Quantum Inc. (0001907982) (Subject)

    11/15/24 7:37:26 AM ET
    $QBTS
    EDP Services
    Technology